BEAVERTON, OREGON - April 11, 2014 - Nathalie Traller, a freshman at Sunset High School, has been diagnosed with Alveolar Soft Part Sarcoma, a rare form of cancer. There is no known successful treatment of the disease, so the Trallers are asking drug companies to bend the rules and allow Nathalie into clinical trials for a new drug that could help her.
(Benjamin Brink/The Oregonian)

As Nathalie Traller, a Beaverton 15-year-old with a rare form of cancer, continues to fight for access to an experimental drug that could treat her, national media outlets are picking up her story.

On Tuesday, Aug. 5, CNBC published an in-depth story on Nathalie's struggle to gain access to experimental treatments, the politics behind drug companies' choice not to provide them, and the outlook for changing the FDA's system for approving exceptions to clinical trial rules.

For more on Nathalie's cancer fight and the sweeping social media campaign behind her cause, read our local coverage, which includes photos, videos and more.